Annachiara Ferrari
- Hepatology top 5%
- Hepatitis C virus research 5
-
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 3
- Emergency Medical Services top 10%
-
- Dialysis and Renal Disease Management 2
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 5
- SARS-CoV-2 detection and testing 2
-
- Lanthanide and Transition Metal Complexes 1
- Co-authors
- A. AlbertíAlessandro VarioR. PistisJonathan FreemanDouglas K. RichardsonGiada SebastianiJames GrayCarlos Ávila-Figueroa
- Journals
- Annals of the New York Academy of Sciences (1 paper)Journal of Hepatology (1 paper)Alimentary Pharmacology & Therapeutics (2 papers)
- Partner nations
- ItalyUnited StatesBelgium
In The Last Decade
Annachiara Ferrari
22 papers receiving 373 citations
Peers
Comparison fields: 5 of 63
- Hepatology 123
- Critical Care and Intensive Care Medicine 28
- Epidemiology 166
- Emergency Medical Services 34
- Nephrology 33
Countries citing papers authored by Annachiara Ferrari
This map shows the geographic impact of Annachiara Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annachiara Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annachiara Ferrari more than expected).
Fields of papers citing papers by Annachiara Ferrari
This network shows the impact of papers produced by Annachiara Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annachiara Ferrari. The network helps show where Annachiara Ferrari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Annachiara Ferrari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 22 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 23 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 13 | |
| 10 | 2020 | 15 | |
| 11 | 2018 | 16 | |
| 12 | 2007 | 2 | |
| 13 | 2005 | 47 | |
| 14 | 2005 | 62 | |
| 15 | Combination of non invasive markers to identify liver fibrosis in HCV patients with persistently normal ALT (PNALT) | 2005 | 1 |
| 16 | 2004 | 40 | |
| 17 | 2003 | 2 | |
| 18 | 1998 | 93 | |
| 19 | Dialysis arthropathy: identification and evaluation of a subset of patients with unexplained inflammatory effusions. | 1997 | 8 |
| 20 | 1965 | 5 |
About Annachiara Ferrari
Annachiara Ferrari is a scholar working on Hepatology, Nephrology and Infectious Diseases, having authored 24 papers that have together received 384 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (3 papers), SARS-CoV-2 detection and testing (2 papers), Dialysis and Renal Disease Management (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). The work is most often cited by research in Hepatology (123 citations), Critical Care and Intensive Care Medicine (28 citations) and Epidemiology (166 citations). Annachiara Ferrari has collaborated with scholars based in Italy, United States and Belgium. Frequent co-authors include A. Albertí, Alessandro Vario, R. Pistis, Jonathan Freeman, Douglas K. Richardson, Giada Sebastiani, James Gray, Carlos Ávila-Figueroa, Donald A. Goldmann and Gaetano Alfano. Their work appears in journals such as Annals of the New York Academy of Sciences, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.